StockData
Annovis Bio, Inc. logo

Annovis Bio, Inc. (ANVS) stock

ANVSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.85−0.01 (-0.71%)

Close on Nov 12, 2026Market cap $36.10MP/E –Yield –

Annovis Bio statistics

59 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 15, 2027 (estimated, after the close)
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 12, 2026

Valuation ratiosIndustry

Market Cap
$36.10M
$280.48M
Enterprise Value
$17.37M
$148.62M

Share statisticsIndustry

Shares Change (YoY)
71.7%
10.9%
Shares Change (QoQ)
49.3%
0.51%
Float
33M
49M
Shares Held by Insiders
23.1%
12.1%
Shares Held by Institutions
25.5%
56.4%

Short sellingIndustry

Short Interest
5M
–
Short Interest Change
-6.38%
-0.76%
Short % of Float
16.3%
9.04%
Short % of Shares Outstanding
12.6%
6.30%
Days to Cover
6.77
5.13

Stock price statisticsIndustry

52-Week High
$5.50
–
52-Week Low
$0.62
–
20-Day Moving Average
$0.97
–
50-Day Moving Average
$1.11
–
200-Day Moving Average
$1.82
–
Average True Range (14)
$0.13
–
Price Change (1 Week)
26.7%
1.51%
Price Change (1 Month)
-16.9%
-2.35%
Price Change (3 Months)
-54.2%
-21.1%
Price Change (6 Months)
-60.2%
-22.6%
Price Change (YTD)
-75.5%
-22.6%
Price Change (1 Year)
-59.8%
-20.7%
Price Change (3 Years)
-85.9%
-27.4%
Price Change (5 Years)
-97.2%
-77.3%
Average Volume (10 Days)
6M
–
Average Volume (20 Days)
3M
–
Average Volume (90 Days)
1M
–
Relative Volume
0.82
0.79
Relative Strength Index (14)
40.9
44.7
Volatility (1 Year)
103.8%
80.4%
Beta (5 Years)
1.92
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-703.7%
-51.2%
Return on Assets (ROA)
-227.7%
-40.6%
Return on Capital Employed (ROCE)
-315.9%
-38.0%

Financial positionIndustry

Quick Ratio
2.95
2.42

EfficiencyIndustry

Asset Turnover
0.00
0.40
Revenue Per Employee
$0
$429.29K
Profits Per Employee
-$6.19M
-$683.67K
Employee Count
8
75
WACC
14.6%
10.1%

Income statement (TTM)Industry

Revenue
$0
$66.37M
Operating Income
-$49.53M
-$20.99M
Net Income
-$49.52M
-$21.61M
EBITDA
-$49.53M
-$16.85M
EPS (Diluted)
-$1.78
-$0.75

Balance sheetIndustry

Net Cash (Debt)
$18.73M
$17.46M
Net Cash Per Share
$0.44
$0.72
Equity (Book Value)
-$4.25M
$53.27M
Book Value Per Share
-$0.10
$1.50
Tangible Book Value
-$4.25M
$26.82M

Cash flow (TTM)Industry

Operating Cash Flow
-$43.34M
-$12.27M

Dividends and yieldsIndustry

Earnings Yield
-137.2%
-20.8%

Taxes and interestIndustry

Income Tax
$0
$74.00K

Scores and fair valueIndustry

Altman Z-Score
-19.05
0.30
Piotroski F-Score
3
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodANVSS&P 500DifferenceANVS per yearS&P 500 per year
1 month-26.3%-2.7%−23.6 pts
3 months-52.9%-1.7%−51.2 pts
Year to date-75.5%+11.9%−87.4 pts
1 year-65.1%+12.0%−77.1 pts
3 years-85.4%+78.2%−163.6 pts-47.3%+21.2%
5 years-97.2%+73.2%−170.4 pts-51.0%+11.6%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

5M ANVS shares were sold short on Oct 30, 2026, down 6.4% from the previous report, or 16.34% of the shares available to trade. At recent volumes it would take 6.8 days to buy them back. Over the last 20 sessions, 69.0% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20265,356,098-6.4%790,9726.8
Oct 15, 20265,720,877-3.0%686,1578.3
Sep 30, 20265,895,922-2.1%990,5736.0
Sep 15, 20266,022,040+20.7%1,889,9183.2
Aug 31, 20264,989,785+0.5%520,4059.6
Aug 14, 20264,964,649-4.4%608,1318.2
Jul 31, 20265,193,076-4.7%549,6849.4
Jul 15, 20265,450,385+12.0%1,079,4705.0
Jun 30, 20264,864,454+1.2%908,3205.4
Jun 15, 20264,804,638-4.3%1,188,7654.0
May 29, 20265,021,073+7.4%1,602,9983.1
May 15, 20264,674,614-3.0%964,6194.8

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?